Squarepoint
NVOS

Squarepoint’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

Squarepoint’s Portfolio NVOS Stock Details NVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,663
Closed -$2.04K – 4166
2023
Q1 		$2.04K Buy
+1,663
New +$2.21K ﹤0.01% 3159

Other funds holding NVOS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $3.12B AUM 21% 1-Year Est. Return

Squarepoint's NVOS Position: Q2 2023 in Review

Squarepoint sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q2 2023, closing a stake of 1,663 shares — an estimated $2.04K sold.

Squarepoint first reported a position in NVOS in Q1 2023 and held it in 1 quarter. The position peaked at $2.04K in Q1 2023. 14 funds tracked by Wall St. Rank hold NVOS as of Q2 2023.

  • Squarepoint reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Squarepoint sold 1,663 Novo Integrated Sciences, Inc. Common Stock shares in Q2 2023, an estimated $2.04K.
  • Squarepoint first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Squarepoint's Novo Integrated Sciences, Inc. Common Stock position peaked at $2.04K in Q1 2023.
  • 14 funds tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q2 2023.

Based on Squarepoint's 13F filing for Q2 2023, filed 14 Aug 2023.